Nucleoside Therapy in Patients With Telomere Biology Disorders

Clinical trial NCT06817590 · RECRUITING

Trial details

NCT number: NCT06817590
Sponsor: Suneet Agarwal
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Telomere Biology Disorders Dyskeratosis Congenita Revesz Syndrome Hoyeraal Hreidarsson Syndrome Telomere Biology Disorders With Bone Marrow Failure Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)Pulmonary Fibrosis, Familial (Telomere Biology Disorder)

Start date: 2025-09-29
Primary completion: 2028-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.